# Focal white matter lesions drive grey matter inflammation and synapse loss.

- **DOI:** [10.1038/s41586-026-10414-w](https://doi.org/10.1038/s41586-026-10414-w)
- **Rating:** Sound (3.4 out of 5)
- **Verdict:** An anatomically precise rodent study links focal demyelination to remote grey-matter inflammation, but its remyelination-necessity claim depends on one pharmacological perturbation.
- **Framework version:** v5.9
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-10-08
- **Evaluation page:** https://www.nabu.science/paper/10.1038%2Fs41586-026-10414-w

## Key claims

1. focal white matter lesions evoke transient neuronal activity changes and microgliosis, with subsequent synapse loss and increased microglial engulfment in the grey matter, which is reversed if myelin regeneration completes.
   - Support: Well-supported
   - Type: Primary finding
   - Basis: time-resolved physiology and histology consistently identify a transient remote grey-matter response
   - Location: Abstract; Fig. 1
2. Grey matter microgliosis is often considered to be detrimental; however, we show that it is an integral part of regeneration and is conserved across three distinct mouse circuits and lesioning methods.
   - Support: Supported
   - Type: Secondary
   - Basis: cross-model occurrence is broad, while the regenerative role is causally tested in one rat circuit
   - Location: Abstract; Fig. 1m–p; Extended Data Fig. 2
3. Preventing these transient changes in the grey matter blocks myelin regeneration in the white matter.
   - Support: Tentative
   - Type: Secondary
   - Basis: one local PLX5622 strategy produced partial remyelination impairment without orthogonal perturbation or rescue
   - Location: Abstract; Fig. 4h–n
4. inducing myelin regeneration failure leads to chronic grey matter neuroinflammation.
   - Support: Supported
   - Type: Secondary
   - Basis: EdU-maintained microgliosis and synaptic engulfment at 28 days support persistence within the focal lesion model
   - Location: Abstract; Fig. 5k–u

## Strengths

- **Anatomically separated circuit tests causality** The olivocerebellar model separates the CCP lesion from inferior-olive neuronal somata by approximately 3.5 mm while preserving axonal density, enabling remote grey-matter responses to be mapped over time.
  - Dimension: contribution
  - Location: Results, “Mapping the circuit after a focal white matter lesion”; Fig. 1a; Extended Data Fig. 1
- **Convergent temporal and multimodal evidence** Histology, fibre photometry, spatial transcriptomics, bulk RNA sequencing, mitochondrial imaging, and ultrastructure collectively track lesion-associated activity, microglial, synaptic, and regenerative changes.
  - Dimension: methodological rigour
  - Location: Figs. 1–5; Methods, “Fibre photometry,” “Spatial DBiT-seq,” and “Electron microscopy”
- **Multiple models establish response breadth** Remote microgliosis is reported with EtBr, lysolecithin, and L-NIO lesions and across rat and mouse circuits, supporting generality of the occurrence-level finding.
  - Dimension: application pathway
  - Location: Results, “Grey matter microgliosis across lesion models”; Fig. 1m–p; Extended Data Fig. 2

## Limitations

- **Necessity claim lacks orthogonal perturbation** The conclusion that inferior-olive microglia are required for distant remyelination rests on local PLX5622-mediated CSF1R inhibition without an independent depletion method or rescue. Spatial depletion controls establish localization but do not exclude intervention-specific effects.
  - Dimension: methodological rigour
  - Location: Results, “Grey matter microglia modulate neuronal activity” and “Remyelination requires grey matter microgliosis”; Fig. 4a–n
- **Central abstract wording exceeds evidence** PLX5622 reduced remyelinated area and axon proportions rather than demonstrating a complete block, while the claim of recapitulating neurodegenerative inflammation rests on a single 28-day failed-regeneration timepoint.
  - Dimension: reporting
  - Location: Abstract; Fig. 4h–n; Fig. 5k–u
- **Disease translation remains preclinical** The work uses female rodents and induced focal lesions, with the causal intervention concentrated in one rat circuit. The Discussion acknowledges that appropriate disease models are still needed.
  - Dimension: application pathway
  - Location: Methods, “Animals” and lesion-model sections; Discussion, paragraph 2

## Reliability checks

Caveats (4 of 4 checks).

- **Results check:** Clean. The reported numbers and statistics are consistent with the stated results.
- **Reporting and transparency:** Noted. Spatial-transcriptomic reporting does not explicitly map transcriptomes to animals and timepoints or specify whether differential-expression tests use animal-level aggregates; its effect on the reported transcriptomic results cannot be determined.
  - Ethics approval: declared · Data availability: declared
- **Reference integrity:** Clean
  - 79 references in manuscript
  - 77 of 77 checkable references found in an index
  - 2 have no canonical index record — counted, but not index-checkable
  - 1 reference confirmed by manual review
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
